| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | BLP1XA3FZA |
| InChI Key | YFHRCLAKZBDRHN-MRXNPFEDSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H24FN3O2S |
| Molecular Weight | 389.5 |
| AlogP | 4.0 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 54.46 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 27.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Ceramide glucosyltransferase inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | 300-560 | 32.5-160 | - | 50-90 | |
|
Epigenetic regulator
Reader
Bromodomain
|
- | - | - | - | 50 | |
|
Epigenetic regulator
Reader
Methyl-lysine/arginine binding protein
Chromodomain
|
- | - | - | - | 50 | |
|
Epigenetic regulator
Reader
Methyl-lysine/arginine binding protein
PWWP domain
|
- | - | - | - | 50 | |
|
Epigenetic regulator
Reader
Methyl-lysine/arginine binding protein
WDR domain
|
- | - | - | - | 50 | |
|
Epigenetic regulator
Reader
Plant homeodomain
|
- | - | - | - | 50 | |
|
Epigenetic regulator
Writer
DNA methyltransferase
|
- | - | - | - | 50 | |
|
Epigenetic regulator
Writer
Protein methyltransferase
PR domain
|
- | - | - | - | 50 | |
|
Epigenetic regulator
Writer
Protein methyltransferase
Protein arginine methyltransferase
|
- | - | - | - | 50 | |
|
Epigenetic regulator
Writer
Protein methyltransferase
SET domain
|
- | - | - | - | 50 | |
|
Epigenetic regulator
Writer
Protein methyltransferase
|
- | - | - | - | 50 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Tay-Sachs Disease | 3 | D013661 | ClinicalTrials |
| Gaucher Disease | 3 | D005776 | ClinicalTrials |
| Sandhoff Disease | 3 | D012497 | ClinicalTrials |
| Gaucher Disease | 3 | D005776 | ClinicalTrials |
| Kidney Diseases, Cystic | 3 | D052177 | ClinicalTrials |
| Fabry Disease | 3 | D000795 | ClinicalTrials |
| Polycystic Kidney, Autosomal Dominant | 2 | D016891 | ClinicalTrials |
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297611 |
| DrugBank | DB14966 |
| FDA SRS | BLP1XA3FZA |
| PubChem | 60199242 |
| SureChEMBL | SCHEMBL12615329 |
| ZINC | ZINC000202143443 |